{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:35:01Z","timestamp":1788816901739,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1A2C3009475"],"award-info":[{"award-number":["NRF-2022R1A2C3009475"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2016M3A9E4947789"],"award-info":[{"award-number":["NRF-2016M3A9E4947789"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A2C2009257"],"award-info":[{"award-number":["NRF-2020R1A2C2009257"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R111A2070098"],"award-info":[{"award-number":["NRF-2022R111A2070098"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003715","name":"Korea Research Institute of Bioscience and Biotechnology","doi-asserted-by":"publisher","award":["KGM5192423"],"award-info":[{"award-number":["KGM5192423"]}],"id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2022-DD128974"],"award-info":[{"award-number":["RS-2022-DD128974"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-54476-8","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T10:02:28Z","timestamp":1737021748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anti-proteolytic regulation of KRAS by USP9X\/NDRG3 in KRAS-driven cancer development"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1165-3173","authenticated-orcid":false,"given":"Han","family":"Koo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Ahm","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minho","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6910-9213","authenticated-orcid":false,"given":"Dong Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8184-5982","authenticated-orcid":false,"given":"Zee-Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hyun","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Mi","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0863-3008","authenticated-orcid":false,"given":"Bo-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-5746","authenticated-orcid":false,"given":"Chul-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3501-212X","authenticated-orcid":false,"given":"Sang J.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4279-805X","authenticated-orcid":false,"given":"Young Il","family":"Yeom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7177-5205","authenticated-orcid":false,"given":"Dong Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"54476_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"54476_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nature03095","volume":"432","author":"C Sawyers","year":"2004","unstructured":"Sawyers, C. Targeted cancer therapy. Nature 432, 294\u2013297 (2004).","journal-title":"Nature"},{"key":"54476_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","volume":"6","author":"L Zhong","year":"2021","unstructured":"Zhong, L. et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal. Transduct. Target. Ther. 6, 201 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"54476_CR4","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nrd4389","volume":"13","author":"AD Cox","year":"2014","unstructured":"Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J. & Der, C. J. Drugging the undruggable RAS: mission possible? Nat. Rev. Drug Discov. 13, 828\u2013851 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"54476_CR5","doi-asserted-by":"crossref","unstructured":"Waters, A. M. & Der, C. J. KRAS: the critical driver and therapeutic target for pancreatic cancer. Cold Spring Harb. Perspect. Med. 8, a031435 (2018).","DOI":"10.1101\/cshperspect.a031435"},{"key":"54476_CR6","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1242\/jcs.182873","volume":"129","author":"GA Hobbs","year":"2016","unstructured":"Hobbs, G. A., Der, C. J. & Rossman, K. L. RAS isoforms and mutations in cancer at a glance. J. Cell Sci. 129, 1287\u20131292 (2016).","journal-title":"J. Cell Sci."},{"key":"54476_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/jnci\/djr523","volume":"104","author":"NT Ihle","year":"2012","unstructured":"Ihle, N. T. et al. Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J. Natl Cancer Inst. 104, 228\u2013239 (2012).","journal-title":"J. Natl Cancer Inst."},{"key":"54476_CR8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nature12796","volume":"503","author":"JM Ostrem","year":"2013","unstructured":"Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A. & Shokat, K. M. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 503, 548\u2013551 (2013).","journal-title":"Nature"},{"key":"54476_CR9","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1158\/1078-0432.CCR-21-3074","volume":"28","author":"EC Nakajima","year":"2022","unstructured":"Nakajima, E. C. et al. FDA approval summary: sotorasib for KRAS G12C-mutated metastatic NSCLC. Clin. Cancer Res. 28, 1482\u20131486 (2022).","journal-title":"Clin. Cancer Res."},{"key":"54476_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40265-023-01839-y","volume":"83","author":"S Dhillon","year":"2023","unstructured":"Dhillon, S. Adagrasib: first approval. Drugs 83, 275\u2013285 (2023).","journal-title":"Drugs"},{"key":"54476_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41586-019-1884-x","volume":"577","author":"JY Xue","year":"2020","unstructured":"Xue, J. Y. et al. Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition. Nature 577, 421\u2013425 (2020).","journal-title":"Nature"},{"key":"54476_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41591-020-0765-z","volume":"26","author":"AN Hata","year":"2020","unstructured":"Hata, A. N. & Shaw, A. T. Resistance looms for KRAS(G12C) inhibitors. Nat. Med. 26, 169\u2013170 (2020).","journal-title":"Nat. Med."},{"key":"54476_CR13","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1096\/fj.09-151464","volume":"24","author":"V Melotte","year":"2010","unstructured":"Melotte, V. et al. The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications. FASEB J. 24, 4153\u20134166 (2010).","journal-title":"FASEB J."},{"key":"54476_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00894-002-0102-0","volume":"9","author":"A Bhaduri","year":"2003","unstructured":"Bhaduri, A., Krishnaswamy, L., Ullal, G. R., Panicker, M. M. & Sowdhamini, R. Fold prediction and comparative modeling of Bdm1: a probable alpha\/beta hydrolase associated with hot water epilepsy. J. Mol. Model. 9, 3\u20138 (2003).","journal-title":"J. Mol. Model."},{"key":"54476_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/prot.10083","volume":"47","author":"E Shaw","year":"2002","unstructured":"Shaw, E., McCue, L. A., Lawrence, C. E. & Dordick, J. S. Identification of a novel class in the alpha\/beta hydrolase fold superfamily: the N-myc differentiation-related. Proteins 47, 163\u2013168 (2002).","journal-title":"Proteins"},{"key":"54476_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/092986612799080284","volume":"19","author":"P Marchot","year":"2012","unstructured":"Marchot, P. & Chatonnet, A. Enzymatic activity and protein interactions in alpha\/beta hydrolase fold proteins: moonlighting versus promiscuity. Protein Pept. Lett. 19, 132\u2013143 (2012).","journal-title":"Protein Pept. Lett."},{"key":"54476_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2174\/092986612799080103","volume":"19","author":"A De Jaco","year":"2012","unstructured":"De Jaco, A., Comoletti, D., Dubi, N., Camp, S. & Taylor, P. Processing of cholinesterase-like alpha\/beta-hydrolase fold proteins: alterations associated with congenital disorders. Protein Pept. Lett. 19, 173\u2013179 (2012).","journal-title":"Protein Pept. Lett."},{"key":"54476_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/ijc.23961","volume":"124","author":"W Wang","year":"2009","unstructured":"Wang, W. et al. NDRG3 is an androgen regulated and prostate enriched gene that promotes in vitro and in vivo prostate cancer cell growth. Int J. Cancer 124, 521\u2013530 (2009).","journal-title":"Int J. Cancer"},{"key":"54476_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.pathol.2016.08.005","volume":"48","author":"J Ma","year":"2016","unstructured":"Ma, J. et al. High expression of NDRG3 associates with positive lymph node metastasis and unfavourable overall survival in laryngeal squamous cell carcinoma. Pathology 48, 691\u2013696 (2016).","journal-title":"Pathology"},{"key":"54476_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/CBM-170711","volume":"21","author":"X Luo","year":"2018","unstructured":"Luo, X. et al. High expression of NDRG3 associates with unfavorable overall survival in non-small cell lung cancer. Cancer Biomark. 21, 461\u2013469 (2018).","journal-title":"Cancer Biomark."},{"key":"54476_CR21","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2147\/OTT.S156814","volume":"11","author":"T Li","year":"2018","unstructured":"Li, T. et al. NDRG3 facilitates colorectal cancer metastasis through activating Src phosphorylation. Onco Targets Ther. 11, 2843\u20132852 (2018).","journal-title":"Onco Targets Ther."},{"key":"54476_CR22","doi-asserted-by":"crossref","unstructured":"Jing, J. S. et al. NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma. Biosci. Rep. 38, BSR20180907 (2018).","DOI":"10.1042\/BSR20180907"},{"key":"54476_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.5483\/BMBRep.2019.52.7.201","volume":"52","author":"J Shi","year":"2019","unstructured":"Shi, J., Zheng, H. & Yuan, L. High NDRG3 expression facilitates HCC metastasis by promoting nuclear translocation of beta-catenin. BMB Rep. 52, 451\u2013456 (2019).","journal-title":"BMB Rep."},{"key":"54476_CR24","first-page":"3886","volume":"12","author":"MC Kim","year":"2019","unstructured":"Kim, M. C., Park, M. H., Kang, S. H. & Bae, Y. K. NDRG3 protein expression is associated with aggressive biologic phenotype and unfavorable outcome in patients with invasive breast cancer. Int. J. Clin. Exp. Pathol. 12, 3886\u20133893 (2019).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"54476_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cell.2015.03.011","volume":"161","author":"DC Lee","year":"2015","unstructured":"Lee, D. C. et al. A lactate-induced response to hypoxia. Cell 161, 595\u2013609 (2015).","journal-title":"Cell"},{"key":"54476_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05692-6","volume":"9","author":"H Adhikari","year":"2018","unstructured":"Adhikari, H. & Counter, C. M. Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability. Nat. Commun. 9, 3646 (2018).","journal-title":"Nat. Commun."},{"key":"54476_CR27","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.molcel.2018.12.001","volume":"73","author":"JR Kovalski","year":"2019","unstructured":"Kovalski, J. R. et al. The functional proximal proteome of oncogenic ras includes mTORC2. Mol. Cell 73, 830\u2013844.e812 (2019).","journal-title":"Mol. Cell"},{"key":"54476_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-021-03592-2","volume":"595","author":"CD Go","year":"2021","unstructured":"Go, C. D. et al. A proximity-dependent biotinylation map of a human cell. Nature 595, 120\u2013124 (2021).","journal-title":"Nature"},{"key":"54476_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nrgastro.2017.12","volume":"14","author":"P Storz","year":"2017","unstructured":"Storz, P. Acinar cell plasticity and development of pancreatic ductal adenocarcinoma. Nat. Rev. Gastroenterol. Hepatol. 14, 296\u2013304 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"54476_CR30","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2007.09.009","volume":"133","author":"O Strobel","year":"2007","unstructured":"Strobel, O. et al. In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia. Gastroenterology 133, 1999\u20132009 (2007).","journal-title":"Gastroenterology"},{"key":"54476_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2353\/ajpath.2007.061176","volume":"171","author":"L Zhu","year":"2007","unstructured":"Zhu, L., Shi, G., Schmidt, C. M., Hruban, R. H. & Konieczny, S. F. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am. J. Pathol. 171, 263\u2013273 (2007).","journal-title":"Am. J. Pathol."},{"key":"54476_CR32","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/onc.2012.210","volume":"32","author":"G Shi","year":"2013","unstructured":"Shi, G. et al. Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia. Oncogene 32, 1950\u20131958 (2013).","journal-title":"Oncogene"},{"key":"54476_CR33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ccr.2011.03.002","volume":"19","author":"A Fukuda","year":"2011","unstructured":"Fukuda, A. et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 19, 441\u2013455 (2011).","journal-title":"Cancer Cell"},{"key":"54476_CR34","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/01.pas.0000126675.59108.80","volume":"28","author":"RH Hruban","year":"2004","unstructured":"Hruban, R. H. et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am. J. Surg. Pathol. 28, 977\u2013987 (2004).","journal-title":"Am. J. Surg. Pathol."},{"key":"54476_CR35","doi-asserted-by":"publisher","first-page":"474905","DOI":"10.1155\/2014\/474905","volume":"2014","author":"M Distler","year":"2014","unstructured":"Distler, M., Aust, D., Weitz, J., Pilarsky, C. & Grutzmann, R. Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN. Biomed. Res. Int. 2014, 474905 (2014).","journal-title":"Biomed. Res. Int."},{"key":"54476_CR36","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nrgastro.2013.120","volume":"10","author":"S Kaur","year":"2013","unstructured":"Kaur, S., Kumar, S., Momi, N., Sasson, A. R. & Batra, S. K. Mucins in pancreatic cancer and its microenvironment. Nat. Rev. Gastroenterol. Hepatol. 10, 607\u2013620 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"54476_CR37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1248\/bpb.27.628","volume":"27","author":"T Sugiki","year":"2004","unstructured":"Sugiki, T., Taketomi, Y., Kikuchi-Yanoshita, R., Murakami, M. & Kudo, I. Association of N-myc downregulated gene 1 with heat-shock cognate protein 70 in mast cells. Biol. Pharm. Bull. 27, 628\u2013633 (2004).","journal-title":"Biol. Pharm. Bull."},{"key":"54476_CR38","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.bbrc.2005.05.050","volume":"332","author":"M Hunter","year":"2005","unstructured":"Hunter, M. et al. NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24. Biochem. Biophys. Res. Commun. 332, 982\u2013992 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"54476_CR39","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1158\/0008-5472.CAN-08-3024","volume":"69","author":"G Ambrosini","year":"2009","unstructured":"Ambrosini, G., Seelman, S. L. & Schwartz, G. K. Differentiation-related gene-1 decreases Bim stability by proteasome-mediated degradation. Cancer Res. 69, 6115\u20136121 (2009).","journal-title":"Cancer Res."},{"key":"54476_CR40","doi-asserted-by":"publisher","first-page":"e844","DOI":"10.1371\/journal.pone.0000844","volume":"2","author":"SK Kachhap","year":"2007","unstructured":"Kachhap, S. K. et al. The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin. PLoS ONE 2, e844 (2007).","journal-title":"PLoS ONE"},{"key":"54476_CR41","doi-asserted-by":"crossref","unstructured":"Kim, G., Lim, S. & Kim, K. D. N-myc downstream-regulated gene 2 (NDRG2) function as a positive regulator of apoptosis: a new insight into NDRG2 as a tumor suppressor. Cells 10, 2649 (2021).","DOI":"10.3390\/cells10102649"},{"key":"54476_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/cas.14716","volume":"112","author":"K Morishita","year":"2021","unstructured":"Morishita, K., Nakahata, S. & Ichikawa, T. Pathophysiological significance of N-myc downstream-regulated gene 2 in cancer development through protein phosphatase 2A phosphorylation regulation. Cancer Sci. 112, 22\u201330 (2021).","journal-title":"Cancer Sci."},{"key":"54476_CR43","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00018-015-1851-0","volume":"72","author":"M Murtaza","year":"2015","unstructured":"Murtaza, M., Jolly, L. A., Gecz, J. & Wood, S. A. La FAM fatale: USP9X in development and disease. Cell Mol. Life Sci. 72, 2075\u20132089 (2015).","journal-title":"Cell Mol. Life Sci."},{"key":"54476_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08646","volume":"463","author":"M Schwickart","year":"2010","unstructured":"Schwickart, M. et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 463, 103\u2013107 (2010).","journal-title":"Nature"},{"key":"54476_CR45","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1172\/JCI97325","volume":"128","author":"OM Khan","year":"2018","unstructured":"Khan, O. M. et al. The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer. J. Clin. Invest 128, 1326\u20131337 (2018).","journal-title":"J. Clin. Invest"},{"key":"54476_CR46","doi-asserted-by":"crossref","unstructured":"Ahearn, I., Zhou, M. & Philips, M. R. Posttranslational modifications of RAS proteins. Cold Spring Harb. Perspect. Med. 8, a031484 (2018).","DOI":"10.1101\/cshperspect.a031484"},{"key":"54476_CR47","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41401-020-00542-y","volume":"42","author":"WH Wang","year":"2021","unstructured":"Wang, W. H. et al. Post-translational modification of KRAS: potential targets for cancer therapy. Acta Pharm. Sin. 42, 1201\u20131211 (2021).","journal-title":"Acta Pharm. Sin."},{"key":"54476_CR48","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41418-019-0395-5","volume":"27","author":"T Abe","year":"2020","unstructured":"Abe, T. et al. LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. Cell Death Differ. 27, 1023\u20131035 (2020).","journal-title":"Cell Death Differ."},{"key":"54476_CR49","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1126\/science.aap8210","volume":"362","author":"JW Bigenzahn","year":"2018","unstructured":"Bigenzahn, J. W. et al. LZTR1 is a regulator of RAS ubiquitination and signaling. Science 362, 1171\u20131177 (2018).","journal-title":"Science"},{"key":"54476_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1593\/neo.14184","volume":"16","author":"S Shukla","year":"2014","unstructured":"Shukla, S. et al. KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated beta-TrCP1 degradation. Neoplasia 16, 115\u2013128 (2014).","journal-title":"Neoplasia"},{"key":"54476_CR51","doi-asserted-by":"publisher","first-page":"ra30","DOI":"10.1126\/scisignal.2002242","volume":"5","author":"WJ Jeong","year":"2012","unstructured":"Jeong, W. J. et al. Ras stabilization through aberrant activation of Wnt\/beta-catenin signaling promotes intestinal tumorigenesis. Sci. Signal 5, ra30 (2012).","journal-title":"Sci. Signal"},{"key":"54476_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08230-6","volume":"10","author":"WJ Jeong","year":"2019","unstructured":"Jeong, W. J. et al. WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation. Nat. Commun. 10, 295 (2019).","journal-title":"Nat. Commun."},{"key":"54476_CR53","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nature11114","volume":"486","author":"PA Perez-Mancera","year":"2012","unstructured":"Perez-Mancera, P. A. et al. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 486, 266\u2013270 (2012).","journal-title":"Nature"},{"key":"54476_CR54","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neo.2017.11.007","volume":"20","author":"A Pal","year":"2018","unstructured":"Pal, A. et al. Usp9x promotes survival in human pancreatic cancer and its inhibition suppresses pancreatic ductal adenocarcinoma in vivo tumor growth. Neoplasia 20, 152\u2013164 (2018).","journal-title":"Neoplasia"},{"key":"54476_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101007","volume":"4","author":"N Perurena","year":"2023","unstructured":"Perurena, N. et al. USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities. Cell Rep. Med. 4, 101007 (2023).","journal-title":"Cell Rep. Med."},{"key":"54476_CR56","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564\u2013576 e516 (2017).","journal-title":"Cell"},{"key":"54476_CR57","doi-asserted-by":"crossref","unstructured":"Kim K. R. et al. Structural and biophysical analyses of human N-Myc downstream-regulated gene 3 (NDRG3) protein. Biomolecules 10, 90 (2020).","DOI":"10.3390\/biom10010090"},{"key":"54476_CR58","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.bbrc.2009.03.068","volume":"382","author":"C Carriere","year":"2009","unstructured":"Carriere, C., Young, A. L., Gunn, J. R., Longnecker, D. S. & Korc, M. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem. Biophys. Res. Commun. 382, 561\u2013565 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"54476_CR59","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54476-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54476-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54476-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T10:02:36Z","timestamp":1737021756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54476-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["54476"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54476-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"628"}}